NewsRx

Search our medical news database

Diebold, Incorporated

Class Action Shareholder Lawsuit Against Diebold Dismissed

Published in Law and Health Weekly, September 20th, 2008

As previously disclosed on December 16, 2005, five shareholder lawsuits were filed against Diebold, Incorporated and certain current and former officers and directors, alleging violations of federal securities laws. These cases were consolidated into a single proceeding in the U.S. District Court for the Northern District of Ohio. On August 22, 2008, the court granted the company's motion to dismiss the consolidated cases, and entered a judgment in favor of Diebold and the other defendants, dismissing the complaint with prejudice.

A separate class action suit against Diebold and certain current and former officers and directors filed by participants in the company's...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook